Mosaic Bio (Hangzhou) Invites You to CSGCT 2025 with Comprehensive Preclinical Research Solutions
01
Company Profile
Moslight (Hangzhou) Biotechnology Co., Ltd.
Abbreviation: Moslait
Booth No.: B20
Moslight is a company specializing in laboratory animal services and related technical support. Its facilities cover a total area of 2,000 square meters, including 1,000 square meters of SPF barrier system facilities, with capacity for 10,000 large and small animal cages. It provides high-quality services to global new drug research and development, universities, research institutes, and hospitals.
02
Product Introduction
Equipped with specialized barrier facilities and 10,000 cages for rats and mice., with supporting functional areas such as cell culture rooms and behavioral laboratories. We offer flexible cage leasing, multi-strain rat/mouse colony management (including execution of specialized protocols), as well as additional veterinary support, experimental assistance, and data traceability services. Our certified team provides rapid response to help you reduce costs and enhance efficiency.
Focusing on the needs of oncology research, we provide professional mouse and rat tumor model services, such as colorectal cancer, breast cancer, liver cancer, lung cancer, lymphoma, and more. Our specialized experimental operations offer robust data support for your research.
Furthermore, our company alsoWe provide models for autoimmune diseases, CNS disorders, and other conditions. Examples include Parkinson’s disease, stroke, PBMC-based models, psoriasis models (commonly induced by IMQ), DSS-induced murine colitis models, alopecia models, liver-related models, and atopic dermatitis models, among others. Our professional team simultaneously offers supporting services such as skin scoring, tissue sampling, and histopathological slide preparation. All data are traceable and compliant with scientific research regulations, facilitating efficient advancement in autoimmune disease research.
In addition to animal husbandry and model establishment, we provide comprehensive pathological testing services covering molecular, tissue, and blood levels. Molecular assays include ELISA, Western Blot (WB), immunohistochemistry, and immunofluorescence for observing cellular dynamics. We also perform complete blood count (CBC) and serum biochemistry tests to assess liver and kidney function, as well as blood glucose and lipid profiles, thereby evaluating metabolic and organ functions. Our professional team and advanced equipment ensure precise and reliable data, catering to scientific research exploration and preclinical drug development, providing robust support for your experiments.
2025 CSGCT Conference
To drive technological breakthroughs, industrial integration, policy alignment, and international cooperation in China’s cell and gene therapy (CGT) sector, and to propel the Chinese CGT industry to the forefront of global competition, the China Society for Cell and Gene Therapy (CSGCT) Conference was established.
Leveraging its close ties with the American Society of Gene & Cell Therapy (ASGCT), the 2025 CSGCT Annual Meeting will bring together leading scientists, clinical experts, multinational pharmaceutical companies, and overseas investment institutions from around the world. The event will showcase the most cutting-edge scientific advances, technologies, applications, and market access insights in the global cell and gene therapy field, while facilitating connections for high-quality collaborative projects and matching overseas investors with investment opportunities. This initiative aims to establish a platform for in-depth exchange and cooperation between China’s cell and gene therapy industry and the global supply chain.
This conference closely addressed the industry's hotspots, pain points, and bottlenecks, featuring1 Main Forum + 15 High-End Sub-Forums, coveringLatest Advances in Global Gene Therapy, Immune Cell Therapy, In Vivo CAR-T, Adult Stem Cells and Exosomes, iPSC-Derived Cell Therapies, Small Nucleic Acid Drugs, Gene Editing, Oncolytic Viruses, and Tumor Vaccines, as well as CMC and Testing, AI-Driven Drug Discovery, Investment and Financing, and Business Development Partnershipsdeep coverage of the entire industry chain.
2025 2nd China Society for Gene and Cell Therapy (CSGCT) Congress
September 12–13, 2025
Zhongguancun National Independent Innovation Demonstration Zone Exhibition and Trading Center [Conference Center]
For more details, scan the QR code to visit the official conference website.
Specially curated for the 2nd China Society of Gene and Cell Therapy (CSGCT) Conference in 2025“2025 CSGCT Conference Project Roadshow” Session, bringing together over 1,000 high-quality domestic and international investment institutions, industrial investors, and decision-makers from government industrial guidance funds; attracting multinational corporations (MNCs) as well as renowned domestic and international medical and pharmaceutical companies seeking business development (BD) collaborations with outstanding projects, products, and technologies; and accelerating the exchange and cooperation on the most distinctive new technologies, new products, and new ecosystems in China’s cell and gene therapy (CGT) sector.
Conference Forum Details
